InvestorsHub Logo
icon url

XenaLives

10/14/16 8:00 AM

#77996 RE: blu_1 #77986

This is not true.... The initial trial was about dosing, by now they are on what the company believes is a therapeutic dose. We also don't know for sure that donepezil couteracts 2-73.

Remember though, maybe only 1/3 or 1/4 have been on 50mg. And, most the subjects are also taking donepezil, which counteracts 273

icon url

frrol

10/14/16 8:34 AM

#78003 RE: blu_1 #77986

More accurately: They are all on their therapeutic MTD according to Missling, and donepezil is hypothesized by a few of us to thwart 2-73 binding to S1.
icon url

LakeshoreLeo1953

10/14/16 9:47 AM

#78012 RE: blu_1 #77986

There is SO MUCH inaccuracy in that assessment.

Better understanding of protocols is best place to point for better
basis for conclusions.